All News
Filter News
Found 6,325 articles
-
NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2023 Business Highlights Conference Call
2/15/2024
NeuroMetrix, Inc. announced that it plans to issue its 2023 fourth quarter and year end business and financial highlights before the opening of the market on February 22, 2024.
-
EnLiSense CCM Advances Validation of Real-Time IBD Inflammatory Biomarker Monitoring with Two Recent Peer-Reviewed Longitudinal Studies
2/15/2024
EnLiSense CCM, a pioneer in non-invasive sweat-sensor technology for real-time health monitoring, is thrilled to announce a groundbreaking advancement in the world of Inflammatory Bowel Disease management.
-
Masimo Announces the First FDA-cleared “Over-the-Counter” Fingertip Pulse Oximeter
2/13/2024
Masimo MightySat ® Medical Provides Clinically Proven Masimo SET ® Pulse Oximetry to Consumers for Medical Use Without a Prescription.
-
Tandem Diabetes Care Launches Tandem Mobi, the World’s Smallest, Durable Automated Insulin Delivery System
2/13/2024
Tandem Diabetes Care, Inc. announced the United States commercial launch of its new Tandem Mobi, the world’s smallest, durable automated insulin delivery system for people living with diabetes.* The company has begun taking orders and shipping to eligible customers in the United States.
-
NeuroMetrix Announces Review of Strategic Options to Promote Growth and Maximize Shareholder Value
2/13/2024
NeuroMetrix, Inc. announced a process to review strategic options to promote growth of its Quell® neuromodulation and DPNCheck® neurodiagnostic businesses and to maximize shareholder value.
-
ZetrOZ Systems to Showcase Sustained Acoustic Medicine at the American Academy of Orthopedic Surgeons Annual Meeting
2/13/2024
ZetrOZ Systems, inventors of sustained acoustic medicine, will display the company's sam® wearable ultrasound unit at the 2024 annual meeting for the American Academy of Orthopedic Surgeons, February 12-16 in San Francisco.
-
Insulet to Present at The Raymond James & Associates 45th Annual Institutional Investors Conference
2/13/2024
Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at The Raymond James & Associates 45th Annual Institutional Investors Conference in Orlando on Tuesday, March 5, 2024 at 11:35 a.m. (Eastern Time).
-
Curavit Successfully Completes a Virtual Clinical Trial for Sana's Investigative Digital Therapeutic to Treat Symptoms of PTSD
2/12/2024
Curavit Clinical Research has successfully completed a decentralized trial for the Sana Device.
-
Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting
2/12/2024
Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology company, will showcase its latest technologies across the orthopedic care continuum at the American Academy of Orthopedic Surgeons Annual Meeting 2024.
-
New Peer-Reviewed Study Finds That Masimo SET® Pulse Oximetry Measures Accurately on Both Black and White People Even During Low Perfusion
2/8/2024
Masimo (NASDAQ: MASI) today announced the findings of a retrospective, peer-reviewed study published in the Journal of Clinical Monitoring and Computing in which Dr. Vikrant Sharma, along with Dr. Steven J. Barker, Dr. William C. Wilson, and colleagues at Masimo performed a focused analysis of previously published data to evaluate the impact of low perfusion on the performance of Masimo SET® pulse oximetry across a variety of skin pigmentations.
-
First Carbonhand prescribed to a US Veteran
2/7/2024
Mr. Lamb has inclusion body myositis, a rare autoimmune disease that primarily affects skeletal muscles with reduced muscle strength and endurance as characteristic symptoms.
-
BlueWind Medical Brings Revi™ Implantable Tibial Neuromodulation Device to Patients in Central Ohio
2/7/2024
BlueWind Medical, Ltd., a pioneer in the development and commercialization of a patient centric implantable Tibial NeuroModulation (iTNM) solution for urge urinary incontinence (UUI), is excited to announce that Revi is now available in Springfield, Ohio at Ohio Valley Surgical Hospital with urologist Dr. Eric Espinosa.
-
Cumulus Neuroscience Named GOOD DESIGN® Award Winner for Cutting-Edge EEG Headset
2/7/2024
Cumulus Neuroscience has been recognized by GOOD DESIGN® Awards, in the medical category for the product design of its first-in-class electroencephalogram headset.
-
Insulet Announces CE Mark Approval of Omnipod® 5 Integration with Abbott FreeStyle Libre 2 Plus Sensor
2/7/2024
Insulet Corporation announced it has received CE mark approval under the European Medical Device Regulation for the added compatibility of the Abbott FreeStyle Libre 2 Plus sensor with Insulet’s Omnipod 5 Automated Insulin Delivery System for individuals aged two years and older with type 1 diabetes.
-
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Second Review
2/6/2024
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that an independent Data Monitoring Committee (DMC) has completed its second review of trial data and recommended the ATH434-201 Phase 2 study continue as planned.
-
Alto Neuroscience Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
2/6/2024
Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) today announced the closing of its previously announced upsized initial public offering of 9,246,000 shares of common stock, which includes the exercise in full by the underwriters of their option to purchase 1,206,000 additional shares, at a public offering price of $16.00 per share.
-
Femasys Inc. Advances Commercial Readiness with Appointment of Richard Spector to New Position of Chief Commercial Officer
2/6/2024
Femasys Inc. today announced the appointment of Richard Spector to chief commercial officer (CCO), effective February 2024.
-
WACKER to exhibit new adhesive, medical solutions at MD&M West
2/5/2024
WACKER Chemical Corporation is showcasing silicone products for the medical industry during the MD&M West tradeshow here, including its USP Class VI SILPURAN® grades for medical devices, prosthetics, orthotics, and wound care applications.
-
Avation Medical raises $22M+ from impressive line-up of new global investors to jump-start sales of the first closed-loop wearable neuromodulation technology for bladder treatment
2/1/2024
[01-February-2024] Avation's Vivally® System, the only FDA-cleared, non-invasive, closed-loop, at-home wearable, changes the way urinary incontinence and urgency caused by overactive bladder syndrome is treated COLUMBUS, Ohio , Feb. 1, 2024 /PRNewswire/ -- Avation Medical , an innovative neuromodulation and digital health company with a mission to make wearable peripheral neuromodula
-
Alto Neuroscience Announces Pricing of Upsized Initial Public Offering
2/1/2024
Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) today announced the pricing of its upsized initial public offering of 8,040,000 shares of common stock at a public offering price of $16.00 per share.